首页> 外文期刊>Stem cell research journal. >Telomere Lengthening from Oocyte to Embryonic Stem Cell
【24h】

Telomere Lengthening from Oocyte to Embryonic Stem Cell

机译:从卵母细胞到胚胎干细胞的端粒延长

获取原文
获取原文并翻译 | 示例
       

摘要

Telomeres are repeated DNA regions that provide protection from enzymatic end-degradation and maintain chromosome stability during DNA replication. In most mammalian somatic cell types, telomeres shorten with each cell cycle. Telomerase, a reverse transcriptase that can elongate telomeres, adds telomeric repeats into chromosome ends, and is involved in maintaining telomere length in germ-line tissues, in adult stem cell, and in most immortal cancer cells. Telomere length is already determined at the moment of fertilization, and during preimplantation; and a detailed understanding of these telomeres elongation program could be important for studying embryo quality, and the origin of the embryonic stem cells; moreover, it has implications for the study of stem cell, regenerative medicine, ageing and cancer. Oocytes have shorter telomeres than somatic cells, but their telomeres lengthen extraordinarily during early cleavage development; however before blastocyst formation there are very low levels of expression of telomerase; even in telomerase-null mice, telomeres may elongate during preimplantation. Recent studies suggest that telomeres lengthen during early preimplantation use a recombination mechanism, and that from the blastocyst stage onwards, telomerase maintains the telomere length established by this recombinant mechanism. Telomere rebuilding subsequent to somatic cell nuclear transfer appears to vary according to species and type of donor cell used. It is speculated that the rate of telomere erosion and the incidence of chromosome abnormalities affect developmental potential of early embryos and may be potential predictors of developmental outcome. The purpose of this chapter is to review characteristic differences of telomere lengthening during the growing face of the oocyte and the spermatozoa, in early development of in vivo and in vitro (cloned, manipulated) produced embryos, in male and female embryos and in embryonic stem cells generated from these embryos.
机译:端粒是重复的DNA区域,可保护其免受酶促末端降解并在DNA复制过程中保持染色体稳定性。在大多数哺乳动物体细胞类型中,端粒随着每个细胞周期而缩短。端粒酶是一种可延长端粒的逆转录酶,可在染色体末端添加端粒重复序列,并参与维持种系组织,成体干细胞和大多数永生癌细胞中的端粒长度。端粒长度在受精时和植入前已经确定;对这些端粒延长程序的详细了解对于研究胚胎质量和胚胎干细胞的起源可能很重要。而且,它对干细胞,再生医学,衰老和癌症的研究具有重要意义。卵母细胞具有比体细胞短的端粒,但是它们的端粒在早期卵裂发育过程中异常延长。然而,在胚泡形成之前,端粒酶的表达水平非常低。即使在端粒酶无效的小鼠中,端粒在植入前也会伸长。最近的研究表明,端粒在植入前的早期就使用重组机制来延长,并且从胚泡阶段开始,端粒酶就可以维持这种重组机制所建立的端粒长度。体细胞核转移后的端粒重建似乎根据所用供体细胞的种类和类型而异。据推测,端粒侵蚀的速率和染色体异常的发生会影响早期胚胎的发育潜能,并且可能是发育结果的潜在预测因子。本章的目的是回顾在卵母细胞和精子的生长过程中,在体内和体外(克隆,操纵)的胚胎,雄性和雌性胚胎以及胚胎干的早期发育过程中端粒延长的特征差异。这些胚胎产生的细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号